Abbott Laboratories has rallied sharply since the prior May “Buy” rating as strength in its core Medical Devices business and the newly acquired Exact Sciences are expected to support strong growth. The company also carries an A+ S&P credit rating with a stable outlook, reinforcing the positive fundamental backdrop.
Abbott Laboratories has rallied sharply since the prior May “Buy” rating as strength in its core Medical Devices business and the newly acquired Exact Sciences are expected to support strong growth. The company also carries an A+ S&P credit rating with a stable outlook, reinforcing the positive fundamental backdrop.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
